Skip to main content
SpringerLink
Log in

Chemotherapie des metastasierenden Mammakarzinoms mit FEC und in Kombination mit B8509–035, einem Blocker des p-170 Proteins

  • Conference paper
Gynäkologie und Geburtshilfe 1992

  • 8 Accesses

Zusammenfassung

Das p-170 Glycoprotein ist ein Membrantransportprotein, dessen Expression eng mit der Ausbildung der „multi drug resistance” (MDR) gekoppelt ist (2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  1. Gietzen, K., Bai, G., Abdallah, F.: Selective inhibition of proliferation by a novel dihydropyridine derivative with anticalmodulin activity in the mammary tumor cell-line ZR-75–1 Med. Sei. Res. 18, 627–629, 1990

    CAS  Google Scholar 

  2. Morrow, C.S., Cowan, K.H.: Mechanisms and clinical significance of multidrug resistance Oncology 2, 55–64, 1988

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Universitäts-Frauenklinik Freiburg, Hugstetter Str. 55, D-79106, Freiburg, Deutschland

    U. Karck, B. Grossmann, F. Rathgeb & H. G. Meerpohl

  2. BYK-Gulden, Konstanz, Deutschland

    F. Rathgeb

Authors
  1. U. Karck
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Grossmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. F. Rathgeb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. G. Meerpohl
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitäts-Frauenklinik, Universität Bonn, Sigmund-Freud-Straße 25, D - 53105, Bonn, Deutschland

    Dieter Krebs

  2. Frauenklinik, Klinikum St. Marien, Mariahilfbergweg 7, D - 92224, Amberg, Deutschland

    Dietrich Berg

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Karck, U., Grossmann, B., Rathgeb, F., Meerpohl, H.G. (1993). Chemotherapie des metastasierenden Mammakarzinoms mit FEC und in Kombination mit B8509–035, einem Blocker des p-170 Proteins. In: Krebs, D., Berg, D. (eds) Gynäkologie und Geburtshilfe 1992. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77857-5_340

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77857-5_340

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77858-2

  • Online ISBN: 978-3-642-77857-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation